Immunosuppression for autoimmune retinopathy

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 573-575

  Jampol, Lee M ^a   Fishman, Gerald A ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; EDITORIAL; ELECTRORETINOGRAPHY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINOPATHY; VISUAL ACUITY; VISUAL FIELD;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACULAR EDEMA; PARANEOPLASTIC SYNDROMES; RETINAL DISEASES;

EID: 65249174002     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.51     Document Type: Editorial

References (12)

1. Ferreyra HA, Jayasunclera T, Khan NW, He S, Lu Y, Heckenlively JR. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127(4):390-397.
2. Forooghian F, MacDonald IM, Heckenlively JR, etal. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008; 146(4):489-495.
3. Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK. Frequency of anti-retinal antibodies in the normal human serum. J Neuroophthalmol. 2008; 28(1):5-11.
4. Forooghian F, Sproule M, Westall C, etal. Electroretinographicabnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol. 2006; 113(2):123-132.
5. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:5.
6. Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with an- tienolase antibodies. Am J Ophthalmol. 2005;139(5):780-794.
7. Heckenlively JR, Aptsiauri N, NusinowitzS, Peng C, Hargrave PA. Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Trans Am Ophthalmol Soc. 1996;94:179-206.
8. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127(5):565-573.
9. Thirkill CE, Roth AM,Takemoto DJ, Tyler NK, Keltner JL. Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. Am J Ophthalmol. 1991;112(2):132-137.
10. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin. Arch Ophthalmol. 1999;117(4):471-477.
11. Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary [published online ahead of print April 12, 2008]. Semin Immunopathol. 2008; 30(2):127-134.
12. Chan JW. Paraneoplastic retinopathies and optic neuropathies. SurvOphthalmol. 2003;48(1):12-38.